Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii

Chemotherapy

Volumn 56, Issue 6, 2010, Pages 466-471

  Özbek, Berna ^a   Şentürk, Aylin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Colistin sulfate; Levofloxacin; Postantibiotic effect; Tigecycline

Indexed keywords

COLISTIN; LEVOFLOXACIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CENTRIFUGATION; CONTROLLED STUDY; DRUG POTENTIATION; IN VITRO STUDY; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; OFLOXACIN; THIENAMYCINS;

EID: 78349254690     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321015     Document Type: Article

References (40)

1. Falagas ME, Bliziotis IA, Siempos II: Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 2006; 10:R48.
2. Giamarellou H, Antoniadou A, Kanellakopoulou K: Acinetobacter baumannii : a universal threat to public health? Int J Antimicrob Agents 2008; 32: 106-119.
3. Garza-González E, Llaca-Díaz JM, Bosques- Padilla FJ, González GM: Prevalence of multidrug- resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii . Chemotherapy 2010; 9: 56: 275-279.
4. Higgins PG, Dammhayn C, Hackel M, Seifert H: Global spread of carbapenem-resistant Acinetobacter baumannii . J Antimicrob Chemother 2010; 65: 233-238.
5. Karageorgopoulos DE, Falagas ME: Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008; 8: 751-762.
6. Peleg AY, Seifert H, Paterson DL: Acinetobacter baumannii : emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-582.
7. Cisneros JM, Rodriguez-Bano J: Nosocomial bacteremia due to Acinetobacter baumannii : epidemiology, clinical features and treatment. Clin Microbiol Infect 2002; 8: 687-693.
8. Entenza JM, Moreillon P: Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Int J Antimicrob Agents 2009; 34: 8.e1-e9.
9. Craig WA, Gudmundsson S: The postantibiotic effect; in Lorian V (ed): Antibiotics in Laboratory Medicine, ed 4. Baltimore, Williams and Wilkins, 1996, pp 296-329.
10. Bundtzen RW, Gerber AU, Cohn DL, Craig WA: Postantibiotic suppression of bacterial growth. Rev Infect Dis 1981; 3: 28-37.
11. McDonald PJ, Craig WA, Kunin CM: Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J Infect Dis 1977; 135: 217-223.
12. Mohr JF, Wanger A, Rex JH: Pharmacokinetic/ pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial Gram-negative infections in critically ill patients. Diagn Microbiol Infect Dis 2004; 48: 125-130.
13. Smith SV, Gould IM: Optimization of antibiotic dosing schedules in the light of increasing antibiotic resistance. Expert Rev Anti Infect Ther 2004; 2: 227-234.
14. Spivey JM: The postantibiotic effect. Clin Pharm 1992; 11: 865-875.
15. Clinical and Laboratory Standards Institute: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, ed 7. Wayne, CLSI, 2006.
16. Hope R, Warner M, Mushtaq S, Ward ME, Parsons T, Livermore DM: Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. J Antimicrob Chemother 2005; 56: 1042-1046.
17. Pillai SK, Moellering RC Jr, Eliopoulos GM: Antimicrobial combinations; in Lorian V (ed): Antibiotics in Laboratory Medicine. Philadelphia, Lippincott Williams and Wilkins, 2005, pp 365-440.
18. Odds FC: Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
19. National Committee for Clinical Laboratory Standards: Methods for determining a bactericidal activity of antimicrobial agents: approved guideline M26-A. Wayne, NCCLS, 1999.
20. Burgess DS: Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance. Chest 1999; 115(suppl 3):19-23.
21. Owen RJ, Li J, Nation RL, Spelman D: In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2007; 59: 473-477.
22. Plachouras D, Giamarellos-Bourboulis EJ, Kentepozidis N, Baziaka F, Karagianni V, Giamarellou H: In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii . Diagn Microbiol Infect Dis 2007; 57: 419-422.
23. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, Kapaskelis A, Nikita D, Michalopoulos A: Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010; 35: 194-199.
24. Ali MZ, Goetz MB: A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24: 796-809.
25. Hatala R, Dinh T, Cook DJ: Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 1996; 24: 717-725.
26. Houston AK, Jones RN: Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin. Diagn Microbiol Infect Dis 1994; 18: 57-59.
27. Minguez F, Ramos C, Barrientos S, Loscos A, Prieto J: Postantibiotic effect of ciprofloxacin compared with that of five other quinolones. Chemotherapy 1991; 37: 420-425.
28. Ozbek B, Otuk G: Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa . Chemotherapy 2009; 55: 446-450.
29. Spangler SK, Bajaksouzian S, Jacobs MR, Appelbaum PC: Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 Gram-positive and -negative bacteria. Antimicrob Agents Chemother 2000; 44: 186-189. (Pubitemid 30010695)
30. Drusano GL, Johnson DE, Rosen M, Standiford HC: Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob Agents Chemother 1993; 37: 483-490.
31. Rodvold KA, Neuhauser M: Pharmacokinetics and pharmacodynamics of fluoroquinolones. Pharmacotherapy 2001; 21: 233-252.
32. Kardas P: Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother 2002; 49: 897-903.
33. Noviello S, Ianniello F, Leone S, Fiore M, Esposito S: In vitro activity of tigecycline: MICs, MBCs, time-kill curves and post-antibiotic effect. J Chemother 2008; 20: 577-580.
34. Pankuch GA, Appelbaum PC: Postantibiotic effect of ceftaroline against Gram-positive organisms. Antimicrob Agents Chemother 2009; 53: 4537-4539.
35. Zhanel GG, Homenuik K, Nichol K, Noreddin A, Vercaigne L, Embil J, Gin A, Karlowsky JA, Hoban DJ: The glycylcyclines: a comparative review with the tetracyclines. Drugs 2004; 64: 63-88.
36. Cunha BA, Domenico P, Cunha CB: Pharmacodynamics of doxycycline. Clin Microbiol Infect 2000; 6: 270-273.
37. Candel FJ, Calvo N, Head J, Sánchez A, Matesanz M, Culebras E, Barrientos A, Picazo J: A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects. Rev Esp Quimioter 2010; 23: 103-108.
38. Dizbay M, Tozlu DK, Cirak MY, Isik Y, Ozdemir K, Arman D: In vitro synergistic activity of tigecycline and colistin against XDR- Acinetobacter baumannii . J Antibiot (Tokyo) 2010; 63: 51-53.
39. Lim TP, Tan TY, Lee W, Sasikala S, Tan TT, Hsu LY, Kwa AL: In vitro activity of various combinations of antimicrobials against carbapenem- resistant Acinetobacter species in Singapore. J Antibiot (Tokyo) 2009; 62: 675-679.
40. Principe L, D'Arezzo S, Capone A, Petrosillo N, Visca P: In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii . Ann Clin Microbiol Antimicrob 2009; 21: 8:18.